CENTOGENE N V's ticker is CNTG and the CUSIP is N1976T109. A total of 14 filers reported holding CENTOGENE N V in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $218,772 | -29.3% | 206,389 | +0.1% | 0.00% | – |
| Q2 2023 | $309,302 | +129.2% | 206,201 | -0.1% | 0.00% | – |
| Q1 2023 | $134,958 | -22.7% | 206,389 | +9.9% | 0.00% | – |
| Q4 2022 | $174,698 | -63.1% | 187,847 | -55.6% | 0.00% | – |
| Q3 2022 | $474,000 | -47.0% | 422,924 | +12.2% | 0.00% | – |
| Q2 2022 | $894,000 | -26.7% | 377,099 | +30.2% | 0.00% | – |
| Q1 2022 | $1,219,000 | +27.6% | 289,616 | +58.5% | 0.00% | – |
| Q4 2021 | $955,000 | -20.2% | 182,728 | +68.0% | 0.00% | – |
| Q3 2021 | $1,197,000 | +1610.0% | 108,744 | +1511.5% | 0.00% | – |
| Q2 2021 | $70,000 | -72.0% | 6,748 | -67.4% | 0.00% | – |
| Q1 2021 | $250,000 | +133.6% | 20,674 | +108.5% | 0.00% | – |
| Q4 2020 | $107,000 | +114.0% | 9,917 | +88.3% | 0.00% | – |
| Q3 2020 | $50,000 | -42.5% | 5,266 | +39.1% | 0.00% | – |
| Q2 2020 | $87,000 | +148.6% | 3,787 | +115.7% | 0.00% | – |
| Q1 2020 | $35,000 | +1650.0% | 1,756 | +1055.3% | 0.00% | – |
| Q4 2019 | $2,000 | – | 152 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PLATINUM INVESTMENT MANAGEMENT LTD | 409,388 | $4,413,000 | 0.10% |
| Walleye Capital LLC | 86,582 | $933,000 | 0.06% |
| Granahan Investment Management | 154,387 | $1,664,000 | 0.04% |
| ROYCE & ASSOCIATES LP | 200,000 | $2,156,000 | 0.02% |
| FEDERATED HERMES, INC. | 324,939 | $3,503,000 | 0.01% |
| Alyeska Investment Group, L.P. | 33,441 | $360,000 | 0.01% |
| Pentwater Capital Management LP | 16,784 | $181,000 | 0.00% |
| Squarepoint Ops LLC | 22,306 | $240,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,601 | $18,000 | 0.00% |
| Laurion Capital Management LP | 15,166 | $163,000 | 0.00% |